SCHEMBL18650710

C=CCOC1O[C@H](CO[C@@H]2O[C@H](CO[C@@H]3O[C@H](CO)[C@@H](C)[C@H](OC(=O)c4ccccc4)[C@H]3OC(=O)c3ccccc3)[C@@H](C)[C@H](OC(=O)c3ccccc3)[C@H]2OC(=O)c2ccccc2)[C@@H](C)[C@H](OC(=O)c2ccccc2)[C@H]1OC(=O)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 12)

	gene	UniProt	supporting neighbours	confidence
▸	LGALS3	P17931	5/20	0.43

▸	LGALS9	O00182	3/20	0.43

▸	LGALS1	P09382	3/20	0.43

▸	LGALS7; LGALS7B	P47929	2/20	0.43

▸	LGALS4	P56470	2/20	0.39

▸	SELP	P16109	8/20	0.38

▸	SELE	P16581	3/20	0.37

▸	MAOB	P27338	1/20	0.36

▸	EPHX2	P34913	1/20	0.34

▸	LGALS8	O00214	1/20	0.34

▸	NT5E	P21589	1/20	0.34

▸	PTPN1	P18031	1/20	0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL18650699	0.92	LGALS3 (0.36)	LGALS3LGALS9LGALS1LGALS7; LGALS7BLGALS4
SCHEMBL18650713	0.92	PTPN1 (0.42)	LGALS3LGALS9LGALS1LGALS7; LGALS7BSELP
SCHEMBL18650697	0.91	LGALS3 (0.41)	LGALS3LGALS9LGALS1LGALS7; LGALS7BLGALS4
SCHEMBL18654198	0.89	LGALS3 (0.45)	LGALS3LGALS9LGALS1LGALS7; LGALS7BLGALS4
SCHEMBL18654204	0.89	LGALS3 (0.45)	LGALS3LGALS9LGALS1LGALS7; LGALS7BLGALS4
SCHEMBL17241861	0.86	LGALS3 (0.48)	LGALS3LGALS9LGALS1LGALS7; LGALS7BLGALS4
SCHEMBL17241860	0.86	LGALS3 (0.48)	LGALS3LGALS9LGALS1LGALS7; LGALS7BLGALS4
SCHEMBL2483143	0.86	LGALS3 (0.48)	LGALS3LGALS9LGALS1LGALS7; LGALS7BLGALS4
SCHEMBL20226186	0.86	LGALS3 (0.48)	LGALS3LGALS9LGALS1LGALS7; LGALS7BLGALS4
SCHEMBL20226195	0.84	PTPN1 (0.44)	PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20170081428-A1	IMMUNOMODULATING BETA-1,6-D-GLUCANS	INNATE BIOTHERAPEUTICS, LLC	2017-03-23	—	—	US	disclosed